The global glucose testing market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of diabetes and obesity in developing countries, which are driving the demand for glucose testing devices.
The global glucose testing market is segmented on the basis of type (0.5uL/0.6uL, 1uL, 1.5uL), by application (hospital, clinic, household) and by region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa). North America accounted for a major share in the global glucose testing market in 2017 owing to its high adoption rate among diabetic patients as well as availability of advanced technologies such as continuous monitoring systems that are not available in other regions such as Asia Pacific and Latin America.
Some Of The Growth Factors Of This Market:
- The Point-of-Care Glucose Testing market is driven by the increasing prevalence of diabetes and obesity, which are major risk factors for diabetes.
- The Point-of-Care Glucose Testing market is also driven by the increasing number of people with type 2 diabetes who are being diagnosed at an earlier age.
- Increasing awareness about the benefits of early diagnosis and treatment for type 2 diabetes will drive the growth in this market.
- Increasing government initiatives to reduce healthcare costs will also drive growth in this market.
Industry Growth Insights published a new data on “Point-of-Care Glucose Testing Market”. The research report is titled “Point-of-Care Glucose Testing Market research by Types (0.5uL/0.6uL, 1uL, 1.5uL, Others), By Applications (Hospital, Clinic, Household), By Players/Companies Roche Holding AG, Abbott, Nova Biomedical, Prodigy Diabetes Care, Johnson & Johnson, Nipro, ACON Laboratories, Inc., Trividia Health, Inc., Panasonic Healthcare Holdings, EKF Diagnostics, Omron, B. Braun, 77 Elektronika, AgaMatrix”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Point-of-Care Glucose Testing Market Research Report
By Type
0.5uL/0.6uL, 1uL, 1.5uL, Others
By Application
Hospital, Clinic, Household
By Companies
Roche Holding AG, Abbott, Nova Biomedical, Prodigy Diabetes Care, Johnson & Johnson, Nipro, ACON Laboratories, Inc., Trividia Health, Inc., Panasonic Healthcare Holdings, EKF Diagnostics, Omron, B. Braun, 77 Elektronika, AgaMatrix
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Point-of-Care Glucose Testing Market Report Segments:
The global Point-of-Care Glucose Testing market is segmented on the basis of:
Types
0.5uL/0.6uL, 1uL, 1.5uL, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Household
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Holding AG
- Abbott
- Nova Biomedical
- Prodigy Diabetes Care
- Johnson & Johnson
- Nipro
- ACON Laboratories, Inc.
- Trividia Health, Inc.
- Panasonic Healthcare Holdings
- EKF Diagnostics
- Omron
- B. Braun
- 77 Elektronika
- AgaMatrix
Highlights of The Point-of-Care Glucose Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0.5uL/0.6uL
- 1uL
- 1.5uL
- Others
- By Application:
- Hospital
- Clinic
- Household
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Point-of-Care Glucose Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Point-of-care glucose testing is a simple and fast way to measure blood sugar levels in people who are not feeling well. A small drop of blood is drawn from a person's fingertip and sent to a laboratory for analysis.
Some of the major players in the point-of-care glucose testing market are Roche Holding AG, Abbott, Nova Biomedical, Prodigy Diabetes Care, Johnson & Johnson, Nipro, ACON Laboratories, Inc., Trividia Health, Inc., Panasonic Healthcare Holdings, EKF Diagnostics, Omron, B. Braun, 77 Elektronika, AgaMatrix.
The point-of-care glucose testing market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Point-of-Care Glucose Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Point-of-Care Glucose Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Point-of-Care Glucose Testing Market - Supply Chain
4.5. Global Point-of-Care Glucose Testing Market Forecast
4.5.1. Point-of-Care Glucose Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Point-of-Care Glucose Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Point-of-Care Glucose Testing Market Absolute $ Opportunity
5. Global Point-of-Care Glucose Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Point-of-Care Glucose Testing Market Size and Volume Forecast by Type
5.3.1. 0.5uL/0.6uL
5.3.2. 1uL
5.3.3. 1.5uL
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Point-of-Care Glucose Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Point-of-Care Glucose Testing Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Household
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Point-of-Care Glucose Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Point-of-Care Glucose Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Point-of-Care Glucose Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Point-of-Care Glucose Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Point-of-Care Glucose Testing Demand Share Forecast, 2019-2026
9. North America Point-of-Care Glucose Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Point-of-Care Glucose Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Point-of-Care Glucose Testing Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Household
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Point-of-Care Glucose Testing Market Size and Volume Forecast by Type
9.7.1. 0.5uL/0.6uL
9.7.2. 1uL
9.7.3. 1.5uL
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Point-of-Care Glucose Testing Demand Share Forecast, 2019-2026
10. Latin America Point-of-Care Glucose Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Point-of-Care Glucose Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Point-of-Care Glucose Testing Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Household
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Point-of-Care Glucose Testing Market Size and Volume Forecast by Type
10.7.1. 0.5uL/0.6uL
10.7.2. 1uL
10.7.3. 1.5uL
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Point-of-Care Glucose Testing Demand Share Forecast, 2019-2026
11. Europe Point-of-Care Glucose Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Point-of-Care Glucose Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Point-of-Care Glucose Testing Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Household
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Point-of-Care Glucose Testing Market Size and Volume Forecast by Type
11.7.1. 0.5uL/0.6uL
11.7.2. 1uL
11.7.3. 1.5uL
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Point-of-Care Glucose Testing Demand Share, 2019-2026
12. Asia Pacific Point-of-Care Glucose Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Point-of-Care Glucose Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Point-of-Care Glucose Testing Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Household
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Point-of-Care Glucose Testing Market Size and Volume Forecast by Type
12.7.1. 0.5uL/0.6uL
12.7.2. 1uL
12.7.3. 1.5uL
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Point-of-Care Glucose Testing Demand Share, 2019-2026
13. Middle East & Africa Point-of-Care Glucose Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Point-of-Care Glucose Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Point-of-Care Glucose Testing Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Household
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Point-of-Care Glucose Testing Market Size and Volume Forecast by Type
13.7.1. 0.5uL/0.6uL
13.7.2. 1uL
13.7.3. 1.5uL
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Point-of-Care Glucose Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Point-of-Care Glucose Testing Market: Market Share Analysis
14.2. Point-of-Care Glucose Testing Distributors and Customers
14.3. Point-of-Care Glucose Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche Holding AG
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nova Biomedical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Prodigy Diabetes Care
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Johnson & Johnson
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nipro
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ACON Laboratories, Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Trividia Health, Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Panasonic Healthcare Holdings
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. EKF Diagnostics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Omron
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. B. Braun
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. 77 Elektronika
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. AgaMatrix
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
